Effects of prolonged anti blood clot treatment after colorectal surgery

Not Applicable

Completed

• Conditions: Colon and rectal surgery, venous thromboembolism; Surgery

• Registration Number: ISRCTN74314169
• Lead Sponsor: Beth Israel Deaconess Medical Center

Brief Summary

2021 results in https://pubmed.ncbi.nlm.nih.gov/33495879/ (added 09/02/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-01-31
• Study Start: 2019-07-10
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 270

Inclusion Criteria

All patients undergoing colon and rectal surgery at BIDMC between 11/1/2017 and 10/31/2018

Exclusion Criteria

1. Patients with contraindication for use of low molecular weight heparin
2. Patients already on anticoagulation for other conditions

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Complications from extended use of enoxaparin, measured using chart review and phone interview at 30 days after surgery<br> 2. Compliance with extended prophylaxis regimen, measured using phone survey at 30 days after surgery<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. Rates of VTE measured using chart review and NSQIP data collection at 30 days after surgery<br> 2. Other complications measured using chart review at 30 days after surgery<br>